Author

Olivier Tabone

ORCID 0000-0001-6021-8640Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

Ema EtchegarayiD· 2 shared Jenny Valladeau‐GuilemondiD· 2 shared Nicolas ChuviniD· 2 shared Paola BonaventuraiD· 2 shared Rasha E. BoulosiD· 2 shared Stéphane DepiliD· 2 shared Yann EstornesiD· 2 shared A. Bolon· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ema EtchegarayORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewedAug 1, 2025

HERV-derived epitopes represent new targets for T-cell based immunotherapies in ovarian cancer

Paola Bonaventura, Audrey Page, Olivier Tabone…·Stéphane Depil

This study identifies HERV-derived epitopes as potential targets for T-cell immunotherapies in ovarian cancer, showing their expression in tumors and immunogenicity in patients.

9 citations

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 23, 2024

Targeting a shared neoepitope derived from non-canonical translation of c-MYC oncogene in cancer cells

Estelle Baulu, A. Bolon, Ema Etchegaray…·Stéphane Depil

The paper identifies a shared neoepitope from non-canonical c-MYC translation in cancer cells that activates T cells to kill tumors without harming normal cells.

DOI 10.1101/2024.05.23.595486

experimental assaydrug response / drug discovery

𝕏 PostBluesky